BioCentury
ARTICLE | Finance

Advancing AlzeCure

AlzeCure plans to bring its Alzheimer’s programs to the clinic with $22M IPO

November 6, 2018 10:27 PM UTC

Stockholm-based AlzeCure Pharma AB is planning to raise SEK200 million ($22 million) in an IPO on NASDAQ First North Premier to bring both arms of its Alzheimer’s disease portfolio to the clinic.

In a prospectus filed on Nov. 6, the company announced plans to sell 14.3 million shares at SEK14 and said it expects to begin trading Nov. 28. ...